Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer

Matrix metalloproteinases (MMP) play a key role in the breakdown of extracellular matrix and in inflammatory processes. MMP1 is the most highly expressed interstitial collagenase degrading fibrillar collagens. Overexpression of MMP1 has been shown in tumor tissues and has been suggested to be associated with tumor invasion and metastasis. Nine haplotype tagging and additional two intronic single nucleotide polymorphisms (SNP) of MMP1 were genotyped in a case control sample, consisting of 635 lung cancer cases with onset of disease below 51 years of age and 1,300 age- and sex-matched cancer-free controls. Two regions of linkage disequilibrium (LD) of MMP1 could be observed: a region of low LD comprising the 5′ region including the promoter and a region of high LD starting from exon 1 to the end of the gene and including the 3′ flanking region. Several SNPs were identified to be individually significantly associated with risk of early-onset lung cancer. The most significant effect was seen for rs1938901 (P = 0.0089), rs193008 (P = 0.0108), and rs996999 (P = 0.0459). For rs996999, significance vanished after correction for multiple testing. For each of these SNPs, the major allele was associated with an increase in risk with an odds ratio between 1.2 and 1.3 (95% confidence interval, 1.0-1.5). The haplotype analysis supported these findings, especially for subgroups with high smoking intensity. In summary, we identified MMP1 to be associated with an increased risk for lung cancer, which was modified by smoking. (Cancer Epidemiol Biomarkers Prev 2008;17(5):1127–35)

[1]  M. Boehnke,et al.  So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. , 2007, American journal of human genetics.

[2]  A. Gazdar,et al.  Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.

[3]  A. C. Pereira,et al.  Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer Cells , 2007, Molecular Cancer Research.

[4]  K. Hemminki,et al.  Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression , 2007, Breast Cancer Research and Treatment.

[5]  Changqing Zeng,et al.  Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression , 2006, Clinical Cancer Research.

[6]  Thomas Meitinger,et al.  SNP-Based Analysis of Genetic Substructure in the German Population , 2006, Human Heredity.

[7]  T. Illig,et al.  Significant association of a M129V independent polymorphism in the 5′ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study , 2006, Journal of Medical Genetics.

[8]  J. D’Armiento,et al.  Activation of the MMP-1 promoter by cigarette smoke in human small airway epithelial cells requires ERK MAP kinase signaling: differential response of the 1G and 2G promoter sequences. , 2006, Proceedings of the American Thoracic Society.

[9]  Paul Scheet,et al.  A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. , 2006, American journal of human genetics.

[10]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[11]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[12]  L. Bonassar,et al.  Matrix metalloproteinase activity synergizes with α2β1 integrins to enhance collagen remodeling , 2005 .

[13]  J Wouter Jukema,et al.  Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. , 2005, Human molecular genetics.

[14]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[15]  C. Gieger,et al.  KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[16]  L. Beckmann,et al.  SDMinP: a program to control the family wise error rate using step-down minP adjusted P-values , 2005, Bioinform..

[17]  J. Chang-Claude,et al.  Haplotype Sharing Analysis Using Mantel Statistics , 2005, Human Heredity.

[18]  D. Christiani,et al.  Matrix Metalloproteinase-1 Promoter Polymorphism and Lung Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[19]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[20]  M. Selman,et al.  MMP-1: the elder of the family. , 2005, The international journal of biochemistry & cell biology.

[21]  J. Heighway,et al.  The use of Allelic Expression Differences to Ascertain Functional Polymorphisms Acting in cis: Analysis of MMP1 Transcripts in Normal Lung Tissue , 2005, Annals of human genetics.

[22]  W. Guo,et al.  Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. , 2004, Carcinogenesis.

[23]  G. Satten,et al.  Comparison of prospective and retrospective methods for haplotype inference in case‐control studies , 2004, Genetic epidemiology.

[24]  Marshall W. Anderson,et al.  A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.

[25]  J. D’Armiento,et al.  Extracellular Regulated Kinase/Mitogen Activated Protein Kinase Is Up-regulated in Pulmonary Emphysema and Mediates Matrix Metalloproteinase-1 Induction by Cigarette Smoke* , 2004, Journal of Biological Chemistry.

[26]  A. Kulig,et al.  An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer. , 2004, Journal of experimental & clinical cancer research : CR.

[27]  S. Rennard,et al.  Cigarette Smoke Stimulates MMP‐1 Production by Human Lung Fibroblasts Through the ERK1/2 Pathway , 2004, COPD.

[28]  G. Satten,et al.  Inference on haplotype effects in case-control studies using unphased genotype data. , 2003, American journal of human genetics.

[29]  M. Spitz,et al.  Risk for smoking-related cancer among relatives of lung cancer patients. , 2003, Cancer research.

[30]  H. Dienemann,et al.  The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. , 2003, Pharmacogenetics.

[31]  Y. Wen,et al.  Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. , 2003, American journal of obstetrics and gynecology.

[32]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[33]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[34]  G. Aust,et al.  Differential Expression and Activity Status of MMP-1, MMP-2 and MMP-9 in Tumor and Stromal Cells of Squamous Cell Carcinomas of the Lung , 2002, Tumor Biology.

[35]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[36]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[37]  J. Mužík,et al.  A newly identified single nucleotide polymorphism in the promoter of the matrix metalloproteinase-1 gene. , 2002, Molecular and cellular probes.

[38]  G. Mills,et al.  A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility , 2001 .

[39]  M. Biondi,et al.  Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Bergemann,et al.  Matrix metalloproteinase-1 and skin ageing in smokers , 2001, The Lancet.

[41]  H. McLeod,et al.  Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy. , 2001, Oncology reports.

[42]  I. Day,et al.  Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. , 2001, Cancer research.

[43]  J. Rutter,et al.  Interstitial collagenases as markers of tumor progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  P. Courtoy,et al.  The matrix metalloproteinase-1 (MMP-1) expression in the human endometrium is inversely regulated by interleukin-1 alpha and sex steroids. , 2000, Ceska gynekologie.

[45]  F. Green,et al.  Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.

[46]  T. Tsuji,et al.  Alterations of extracellular matrix induced by tobacco smoke extract , 2000, Archives of Dermatological Research.

[47]  P. Davaris,et al.  Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. , 1999, Human pathology.

[48]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[49]  J. Gusella,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. , 1998, Cancer research.

[50]  H. Wichmann,et al.  Risk factors for lung cancer in young adults. , 1998, American journal of epidemiology.

[51]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[52]  G. Swanson,et al.  Genetic analysis of families with nonsmoking lung cancer probands , 1997, Genetic epidemiology.

[53]  G. Swanson,et al.  Familial risk of lung cancer among nonsmokers and their relatives. , 1996, American journal of epidemiology.

[54]  John E. Fothergill,et al.  Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer , 1996, Nature Medicine.

[55]  T. Sellers,et al.  Evidence for a major gene effect in early-onset lung cancer. , 1993, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[56]  S. S. Young,et al.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[57]  C. Amos,et al.  Host factors in lung cancer risk: a review of interdisciplinary studies. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.

[59]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.